The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a...